1. Home
  2. MRK vs JNJ Comparison

MRK vs JNJ Comparison

Compare MRK & JNJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Merck & Company Inc. (new)

MRK

Merck & Company Inc. (new)

HOLD

Current Price

$153.15

Market Cap

317.8B

Sector

Health Care

ML Signal

HOLD

Logo Johnson & Johnson

JNJ

Johnson & Johnson

HOLD

Current Price

$269.51

Market Cap

542.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRK
JNJ
Founded
2000
1886
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
317.8B
542.4B
IPO Year
1995
2003

Fundamental Metrics

Financial Performance
Metric
MRK
JNJ
Price
$153.15
$269.51
Analyst Decision
Buy
Buy
Analyst Count
17
20
Target Price
$125.59
$238.20
AVG Volume (30 Days)
5.8M
5.2M
Earning Date
04-30-2026
04-14-2026
Dividend Yield
3.06%
2.36%
EPS Growth
8.01
90.50
EPS
N/A
4.41
Revenue
$65,011,000,000.00
N/A
Revenue This Year
$3.61
$6.63
Revenue Next Year
$5.41
$7.43
P/E Ratio
N/A
$61.10
Revenue Growth
1.31
N/A
52 Week Low
$77.58
$175.74
52 Week High
$157.00
$281.07

Technical Indicators

Market Signals
Indicator
MRK
JNJ
Relative Strength Index (RSI) 57.90 47.78
Support Level $145.75 $262.26
Resistance Level $152.80 $269.43
Average True Range (ATR) 2.63 4.71
MACD -0.72 -0.70
Stochastic Oscillator 57.63 26.32

Price Performance

Historical Comparison
MRK
JNJ

About MRK Merck & Company Inc. (new)

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).

About JNJ Johnson & Johnson

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.

Share on Social Networks: